BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1247997)

  • 1. Pituitary role in the growth of metastasizing MRMT-1 mammary carcinoma in rats.
    Harada Y
    Cancer Res; 1976 Jan; 36(1):18-22. PubMed ID: 1247997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased incidence of mammary tumors in the female rat grafted with multiple pituitaries.
    Welsch CW; Jenkins TW; Meites J
    Cancer Res; 1970 Apr; 30(4):1024-9. PubMed ID: 5504344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
    Rose DP; Noonan JJ
    Cancer Res; 1982 Jan; 42(1):35-8. PubMed ID: 6797725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
    Gandilhon P; Mélançon R; Djiane J; Kelly PA
    J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats.
    Heuson JC; Legros N; Heimann R
    Cancer Res; 1972 Feb; 32(2):233-8. PubMed ID: 5058184
    [No Abstract]   [Full Text] [Related]  

  • 6. Permissive role of the pituitary in the induction and growth of estrogen-dependent renal tumors.
    Lin YC; Loring JM; Villee CA
    Cancer Res; 1982 Mar; 42(3):1015-9. PubMed ID: 6800644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between estrogens, prolactin, and growth hormone on the growth of N-nitrosomethylurea-induced rat mammary tumors.
    Rose DP; Gottardis M
    Anticancer Res; 1985; 5(4):397-402. PubMed ID: 4037735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypophysectomy, pituitary gland homogenates and transplants, and prolactin on photoreceptor destruction.
    O'Steen WK; Kraeer SL
    Invest Ophthalmol Vis Sci; 1977 Oct; 16(10):940-6. PubMed ID: 908647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of various oncogenic agents on tumor-producing capabilities of series D BALB-c mammary nodule outgrowth lines.
    Medina D; DeOme KB
    J Natl Cancer Inst; 1970 Aug; 45(2):353-63. PubMed ID: 4324612
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparation of growth hormone from a rat mammosomatotropic pituitary tumor.
    Groves WE; Sells BH
    Cancer Res; 1969 Feb; 29(2):409-13. PubMed ID: 5765421
    [No Abstract]   [Full Text] [Related]  

  • 11. Serial transplantation of methylcholanthrene-treated mammary nodule outgrowth line D1.
    Medina D
    J Natl Cancer Inst; 1972 May; 48(5):1363-70. PubMed ID: 5030953
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological and morphological characteristics of mammary tumors in GR mice.
    van Nie R; Dux A
    J Natl Cancer Inst; 1971 Apr; 46(4):885-97. PubMed ID: 5573773
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of prolactin-induced mammary cancer in C3Hf (XVII) mice with the trans isomer of bromotriphenylethylene.
    Drosdowsky M; Edery M; Guggiari M; Montes-Rendon A; Rudali G; Vives C
    Cancer Res; 1980 May; 40(5):1674-9. PubMed ID: 6245799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of hormones to inhibition of mammary tumor development by underfeeding during the "critical period" after carcinogen administration.
    Sylvester PW; Aylsworth CF; Meites J
    Cancer Res; 1981 Apr; 41(4):1384-8. PubMed ID: 6783295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of multiple pituitary homografts or progesterone on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Welsch CW; Clemens JA; Meites J
    J Natl Cancer Inst; 1968 Aug; 41(2):465-71. PubMed ID: 5671287
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of metastasizing carcinoma in rats and their biological characteristics.
    Harada Y
    Acta Pathol Jpn; 1975 Jul; 25(4):451-61. PubMed ID: 170787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperplastic lesions of mouse mammary glands after treatment with 3-methylcholanthrene.
    Faulkin LJ
    J Natl Cancer Inst; 1966 Feb; 36(2):289-97. PubMed ID: 4286277
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of rolipram-induced increase in the incidence of mammary adenocarcinoma: histopathological study of a 104-week oral carcinogenicity study in female Sprague-Dawley rats.
    Nishiyama S; Okudaira M; Saito N
    Arch Toxicol; 2006 Feb; 80(2):88-97. PubMed ID: 16167140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin-dependent rat mammary cancer: a model for man?
    Pearson OH; Llerena O; Llerena L; Molina A; Butler T
    Trans Assoc Am Physicians; 1969; 82():225-38. PubMed ID: 5375151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hormone stimulation, dose, and time of administration of carcinogen on carcinogen-induced mammary tumors from preneoplastic nodule outgrowths.
    Medina D
    J Natl Cancer Inst; 1971 Apr; 46(4):909-16. PubMed ID: 5573775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.